Tuesday, June 1, 2021

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug Lilly said it is engaged in active dialogue with the Indian government and regulatory authorities to donate bamlanivimab and etesevimab in order to speed up access and provide treatment options for patients with COVID-19.

from Moneycontrol Business News https://ift.tt/3p6Q9cZ
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

F&O Talk| Nifty extends losing streak for 4th week, bearish signals deepen: Sudeep Shah

The Nifty index is on a four-week losing streak, influenced by underwhelming Q1 earnings and global trade concerns. Nifty Bank outperformed ...